About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Pilot plant QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×
news
Company News Events Insights Webinars
BioDuro-Sundia’s China Analytical Lab Passes EU QP Audit
SAN DIEGO and SHANGHAI, April 23, 2021 – BioDuro-Sundia, a leading drug discovery and development services organization backed by Advent International, announced today its Analytical Laboratory i
April 23, 2021
BioDuro-Sundia Microbiology Laboratory Receives Quality Certification from Wuxi City CDC
Wuxi, April 13, 2021 – The BSL-2 Microbiology Laboratory in BioDuro-Sundia’s Wuxi R&D Center passed a comprehensive on-site inspection from the Wuxi City Center for Disease Control and Prevention (CDC)
April 13, 2021
BioDuro-Sundia Services Support Tianjin Jun’an Bio Regulatory Approval for Diabetes Drug
Shanghai, April 13, 2021 – BioDuro-Sundia has helped its partner, Tianjin Jun’an Bio-Pharmaceutical Co., LTD., obtain the Approval Notice of Supplement Application for Drug by The National Medical Products Administration (NMPA)
April 13, 2021
BioDuro-Sundia Completes First GMP Preparation of Clinical Samples at New China Site
SAN DIEGO and SHANGHAI, April 13, 2021 – BioDuro-Sundia, a leading drug discovery and development services organization backed by Advent International, announced today it has successfully complet
April 13, 2021
BioDuro-Sundia Receives Excellent Partner Award from BioFront Drug Discovery Innovation Center
SHANGHAI and BEIJING, February 25, 2021 – BioDuro-Sundia has received the award “Excellent Partner 2020” from BioFront Drug Discovery Innovation Center, in recognition of the excellent services a
February 25, 2021
Total 78 12345678...1516
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all